Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcomeAndrea Rinaldi, Francesco Bertoni, Francesco Forconi et al.|Blood|2010Cited by 189
Genomic lesions associated with a different clinical outcome in diffuse large B‐Cell lymphoma treated with R‐CHOP‐21Marta Scandurra, Francesco Bertoni, Michael Mian et al.|British Journal of Haematology|2010Cited by 52
Subgroups of Diffuse Large B-Cell Lymphoma (DLBCL) with Different Genomic Lesions and Clinical Course During Treatment with R-CHOP.Marta Scandurra, Francesco Bertoni, Michael Mian et al.|Blood|2009Cited by 0
Array-CGH Identifies Regions, Including the FOXP1 Locus, Associated with Different Clinical Outcome in Diffuse Large B-Cell Lymphomas (DLBCL) Treated with R-CHOPMarta Scandurra, Francesco Bertoni, Paola M. V. Rancoita et al.|Blood|2008Cited by 0